Last reviewed · How we verify
NCT06059911
Pre-workout Supplementation and Basketball
NA trial testing Multi-ingredient dietary supplement (caffeine, creatine monohydrate, β-alanine, citrulline malate, BCAA) in Sport Performance in 36 participants. Status unknown.
15 December 2023
Quick facts
| Lead sponsor | Athanasios Z. Jamurtas |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 15 June 2022 |
| Primary completion | 15 December 2023 |
| Estimated completion | 15 June 2024 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Multi-ingredient dietary supplement (caffeine, creatine monohydrate, β-alanine, citrulline malate, BCAA)
- Placebo dietary supplement (97% maltodextrin)
Conditions studied
- Sport Performance — all drugs for Sport Performance →
Sponsor
Athanasios Z. Jamurtas
Who can join
Adults 18 to 41, male only, with Sport Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pre-workout supplements (PWS) consumption in recreationally or physically trained males lead to many performance-enhancing benefits, including improvements in mean power output during single and repeated sprints, agility, reaction times, lower body muscular endurance and reduced fatigue. PWS ingestion also improves anaerobic performance and prolongs time to exhaustion during high-intensity intermittent exercise. However, PWSs' effectiveness is not constant, as they do not alter anaerobic power, jumping performance or blood lactate concentrations after a training session, at least in recreationally trained males and strength-power athletes. Moreover, the effects of long-term PWS supplementation, where some nutritional agents were combined (e.g., β-alanine, creatine, citrulline malate, etc.) to assess endurance-trained runners or elite cyclists' performance, are mixed and less clear. Even though the popularity of PWS use has increased among trained/professional athletes, most of the data in this area are derived from recreationally and not from well-trained athletes of a competitive level (especially in team sports). Therefore, the present study aimed to examine the acute and chronic effects of a PWS, containing 200 mg caffeine, 3.3 g creatine monohydrate, 3.2 g βalanine, 6 g citrulline malate and 5 g BCAA per dose, on shooting, jumping, sprinting, agility, aerobic and anaerobic performance in well-trained basketball players.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Four Weeks of In-Season Pre-Workout Supplementation on Performance, Body Composition, Muscle Damage, and Health-Related Markers in Basketball Players: A Randomized Controlled Study.
Douligeris A, Methenitis S, Stavropoulos-Kalinoglou A, Panayiotou G, et al · · 2024 · cited 1× · PMID 38804451 · DOI 10.3390/jfmk9020085
Verify or expand the search:
- PubMed search for NCT06059911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sport Performance
Currently open trials in the same condition.
- NCT07493837 — Land- and Water-based Inspiratory Muscle Training in Young Swimmers · NA · recruiting
- NCT07358936 — THE EFFECTS OF CORRECTIVE EXERCISE AND KT APPLICATIONS IN YOUNG BASKETBALL PLAYERS · NA · recruiting
- NCT07288892 — Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery · NA · recruiting
- NCT07135934 — Effects of Single Sodium Bicarbonate Supplementation on National-Level Finswimming Performance · NA · recruiting
- NCT07096492 — Strength and Plyometric Training in Swimming · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06059911 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Athanasios Z. Jamurtas
- Last refreshed: 3 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing